Catalyst Wire Dossier Catalyst Wire Dossier

ALFQ

Adjuvant Lipid Formulation with QS-21
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALFQ, covering 2026-01-30 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adults [Phase 1]

See pricing